[Source: Wall Street Journal] – The Food and Drug Administration is devising guidelines that could accelerate testing and approval of multidrug regimens for some of the world’s most deadly diseases.
At least two pharmaceutical consortia are poised to take advantage of the forthcoming policy: a group of 10 drug companies and several nonprofit organizations convened by the Bill and Melinda Gates Foundation to develop medicines to fight tuberculosis; and pharmaceutical giants Merck & Co. and AstraZeneca PLC, which are jointly testing two anticancer agents.
For more information: FDA Is Easing Way for Drug Cocktails